Nanomedicine has made significant advances in clinical applications since the late-20th
century, in part due to its distinct advantages in biocompatibility, potency, and novel …

In conventional drug administration, drug molecules cross multiple biological barriers,
distribute randomly in the tissues, and can release insufficient concentrations at the desired …

This chapter highlights the advances in microfluidic systems that can synthesize libraries of
nanoparticles in a well-controlled, reproducible and high-throughput manner. In fact …

Microfluidic technologies with precise fluid control and rapid microscale mixing have
attracted widespread interest in the fabrication and engineering of nanomaterials for drug …

Nanoparticles (NPs) have attracted tremendous interest in drug delivery in the past decades.
Microfluidics offers a promising strategy for making NPs for drug delivery due to its capability …

Microfluidic technologies employ nano and microscale fabrication techniques to develop
highly controllable and reproducible fluidic microenvironments. Utilizing microfluidics, lead …

The use of nanoparticles (NPs) in nanomedicine holds great promise for the treatment of
diseases for which conventional therapies present serious limitations. Additionally, NPs can …

Nanoparticle systems are functional carriers that can be used in the cancer therapy field for
the delivery of a variety of hydrophobic and/or hydrophilic drugs. Recently, the advent of …

Microfluidic devices are mircoscale fluidic circuits used to manipulate liquids at the nanoliter
scale. The ability to control the mixing of fluids and the continuous nature of the process …

Particles synthesized from biodegradable polymers hold great potential as controlled drug
delivery systems. Continuous flow platforms based on microfluidics offer attractive …